Skip to main content
logo
Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
1.470
-0.020 (-1.34%)
At close: Oct 8, 2025, 4:00 PM EDT
1.520
+0.050 (3.40%)
After-hours: Oct 8, 2025, 7:45 PM EDT

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Immuno-inflammatory Disorders Therapies
41.10M
Log In
Log In
Immuno-inflammatory Disorders Therapies Growth
13.89%
Log In
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
United States
41.10M
Log In
Log In
United States Growth
13.89%
Log In
Log In